BioSpace News Archive

Vela Diagnostics’ automated COVID-19 detection kit receives Emergency Use Authorization from the FDA.

Emergency Use Authorization request targets the same population as is currently permitted under FDA Expanded Access Protocol

Vivet Therapeutics and Pfizer Inc. announced that they have entered into a manufacturing agreement, under which Pfizer will provide clinical supply for a Phase 1/2 clinical trial evaluating Vivet’s proprietary, investigational gene therapy, VTX-801, for the potential treatment of Wilson disease, a rare and potentially life-threatening liver disorder.

Published research using the Parsortix system to isolate CTC clusters from blood confirms the role of intra-tumour hypoxia in promoting metastatic breast cancer

Minoryx will receive an upfront and milestone payments of up to $78 million, as well as double digit royalties on annual net sales

Data from Phase IIa show potent effect of Epeleuton on Triglyceride and HbA1C levels

Abacus Diagnostica is a small Finnish company developing and manufacturing assays and devices for rapid molecular diagnostics.

Havn Retail, a core pillar of Havn Life continues to reach milestones as the company works towards its launch of a line of retail products

Centogene N.V., a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, announced the opening of its new COVID-19 testing facility at Düsseldorf Airport.

This represents the third successful regulatory approval globally for GW’s plant-derived cannabis-based medicine